|
US3565924A
(en)
|
1968-07-01 |
1971-02-23 |
Wisconsin Alumni Res Found |
25-hydroxycholfcalciferol
|
|
US3833622A
(en)
|
1969-03-17 |
1974-09-03 |
Upjohn Co |
Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds
|
|
US3974272A
(en)
|
1972-09-01 |
1976-08-10 |
Merck & Co., Inc. |
Palatable cholestyramine coacervate compositions
|
|
US3880894A
(en)
|
1974-05-24 |
1975-04-29 |
Wisconsin Alumni Res Found |
1,25-Dihydroxyergocalciferol
|
|
US4004003A
(en)
|
1974-08-28 |
1977-01-18 |
The Upjohn Company |
25-Hydroxycalciferol compounds for treatment of steroid-induced osteoporosis
|
|
US4230701A
(en)
|
1979-03-21 |
1980-10-28 |
Hoffmann-La Roche Inc. |
Administration of biologically active vitamin D3 and vitamin D2 materials
|
|
US4335120A
(en)
|
1979-03-21 |
1982-06-15 |
Hoffmann-La Roche Inc. |
Administration of biologically active vitamin D3 and vitamin D2 materials
|
|
JPS55139320A
(en)
|
1979-04-16 |
1980-10-31 |
Teijin Ltd |
Bone metabolism regulator
|
|
US4442093A
(en)
|
1981-05-15 |
1984-04-10 |
Kureha Kagaku Kogyo Kabushiki Kaisha |
Method for administering 24,25-dihydroxycholecalciferol to persons suffering from hypercalcemia
|
|
JPS57188520A
(en)
|
1981-05-15 |
1982-11-19 |
Kureha Chem Ind Co Ltd |
Antihyperkalemia
|
|
JPS5832823A
(en)
|
1981-08-20 |
1983-02-25 |
Chugai Pharmaceut Co Ltd |
Cancer eliminating agent
|
|
JPS58206524A
(en)
|
1982-05-26 |
1983-12-01 |
Kureha Chem Ind Co Ltd |
Antitumor agent
|
|
US4448721A
(en)
|
1982-09-20 |
1984-05-15 |
Wisconsin Alumni Research Foundation |
Hydroxyvitamin D2 compounds and process for preparing same
|
|
US4721613A
(en)
|
1982-12-13 |
1988-01-26 |
Alza Corporation |
Delivery system comprising means for shielding a multiplicity of reservoirs in selected environment of use
|
|
JPS59155309A
(en)
|
1983-02-22 |
1984-09-04 |
Teijin Ltd |
Active type vitamin d3 composition and its preparation
|
|
US4684524A
(en)
|
1984-03-19 |
1987-08-04 |
Alza Corporation |
Rate controlled dispenser for administering beneficial agent
|
|
US4555364A
(en)
|
1984-11-01 |
1985-11-26 |
Wisconsin Alumni Research Foundation |
Method for preparing 1-hydroxyvitamin D compounds
|
|
US4695591A
(en)
|
1985-03-29 |
1987-09-22 |
Schering Corporation |
Controlled release dosage forms comprising hydroxypropylmethylcellulose
|
|
US4668517A
(en)
|
1985-04-04 |
1987-05-26 |
Norwich Eaton Pharmaceuticals, Inc. |
Furazolidone dosage form
|
|
EP0207638B1
(en)
|
1985-06-04 |
1990-12-19 |
Teijin Limited |
Sustained-release pharmaceutical preparation
|
|
JPS61293911A
(en)
|
1985-06-24 |
1986-12-24 |
Teisan Seiyaku Kk |
Sustained release preparation
|
|
US5167965A
(en)
|
1987-02-09 |
1992-12-01 |
The Dow Chemical Company |
Palatable cholestyramine granules, tablets and methods for preparation thereof
|
|
US4892821A
(en)
|
1987-07-08 |
1990-01-09 |
Taisho Pharmaceutical Co., Ltd. |
Method for preparing vitamin D compounds
|
|
US4997824A
(en)
|
1987-07-22 |
1991-03-05 |
Teva Pharmaceutical Industries Ltd. |
Combination of cholecalciferol derivatives for the treatment of renal bone disease
|
|
US5602116A
(en)
|
1988-08-02 |
1997-02-11 |
Bone Care International, Inc. |
Method for treating and preventing secondary hyperparathyroidism
|
|
US5869473A
(en)
|
1988-08-02 |
1999-02-09 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
|
US5104864A
(en)
|
1988-08-02 |
1992-04-14 |
Bone Care International, Inc. |
Method for treating and preventing loss of bone mass
|
|
JP2893191B2
(en)
|
1988-11-08 |
1999-05-17 |
武田薬品工業株式会社 |
Controlled release matrix agent
|
|
JP2525478B2
(en)
|
1989-03-01 |
1996-08-21 |
帝人株式会社 |
Active Vitamin D with improved stability (3) Lower solid preparation
|
|
JPH02240024A
(en)
|
1989-03-13 |
1990-09-25 |
Ss Pharmaceut Co Ltd |
Composition for active type vitamin d3s preparation
|
|
US5026559A
(en)
|
1989-04-03 |
1991-06-25 |
Kinaform Technology, Inc. |
Sustained-release pharmaceutical preparation
|
|
GB9004544D0
(en)
|
1990-03-01 |
1990-04-25 |
Leo Pharm Prod Ltd |
Novel treatment ii
|
|
JP2845342B2
(en)
|
1990-04-28 |
1999-01-13 |
大正製薬株式会社 |
Vitamin D Lower 3 Derivative-Containing Solid Preparation Composition
|
|
JPH04198129A
(en)
|
1990-11-28 |
1992-07-17 |
Sumitomo Pharmaceut Co Ltd |
Composition containing active vitamin D↓3 types
|
|
JP2893140B2
(en)
|
1990-11-30 |
1999-05-17 |
エスエス製薬株式会社 |
Stable vitamin D preparation
|
|
JPH04288016A
(en)
|
1991-03-14 |
1992-10-13 |
Tokai Capsule Kk |
Production of soft capsule agent of active type vitamin d3s
|
|
ATE144424T1
(en)
|
1991-04-09 |
1996-11-15 |
Takeda Chemical Industries Ltd |
STABILIZED VITAMIN D MEDICINAL PRODUCT
|
|
US5693615A
(en)
|
1991-06-05 |
1997-12-02 |
The Procter & Gamble Company |
Therapeutic compositions for osteoinduction
|
|
US6001884A
(en)
|
1991-08-23 |
1999-12-14 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
|
US6313146B1
(en)
|
1991-08-23 |
2001-11-06 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
|
US6031003A
(en)
|
1991-08-23 |
2000-02-29 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
|
US6011068A
(en)
|
1991-08-23 |
2000-01-04 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
|
US5266331A
(en)
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
|
US5472712A
(en)
|
1991-12-24 |
1995-12-05 |
Euroceltique, S.A. |
Controlled-release formulations coated with aqueous dispersions of ethylcellulose
|
|
US5160742A
(en)
|
1991-12-31 |
1992-11-03 |
Abbott Laboratories |
System for delivering an active substance for sustained release
|
|
US5795882A
(en)
|
1992-06-22 |
1998-08-18 |
Bone Care International, Inc. |
Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
|
|
ATE211387T1
(en)
|
1992-06-22 |
2002-01-15 |
Bone Care Int Inc |
ORAL 1ALPHA-HYDROXYPREVITAMIN D
|
|
US5354743A
(en)
|
1992-09-15 |
1994-10-11 |
Thys Jacobs Susan |
Method for the treatment of premenstrual syndrome with vitamin D
|
|
US5431917A
(en)
|
1992-10-08 |
1995-07-11 |
Japan Elanco Company, Ltd. |
Hard capsule for pharmaceutical drugs and method for producing the same
|
|
US5342626A
(en)
|
1993-04-27 |
1994-08-30 |
Merck & Co., Inc. |
Composition and process for gelatin-free soft capsules
|
|
JP2684587B2
(en)
|
1993-06-21 |
1997-12-03 |
呉羽化学工業株式会社 |
Inhibitor of bone loss in renal osteodystrophy
|
|
US6121469A
(en)
|
1993-12-23 |
2000-09-19 |
The Regents Of The University Of California |
Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs
|
|
JPH07242550A
(en)
|
1994-03-02 |
1995-09-19 |
Teijin Ltd |
Therapeutic agent for secondary hyperparathyroidism
|
|
IL110117A0
(en)
|
1994-06-24 |
1994-10-07 |
Univ Ben Gurion |
Pharmaceutical compositions comprising vitamin-d analogs
|
|
SE9402422D0
(en)
|
1994-07-08 |
1994-07-08 |
Astra Ab |
New beads for controlled release and a pharmaceutical preparation containing the same
|
|
EP0769936A1
(en)
|
1994-07-22 |
1997-05-02 |
G.D. Searle & Co. |
Self-emulsifying drug delivery system
|
|
JPH0892098A
(en)
|
1994-09-27 |
1996-04-09 |
Teijin Ltd |
Therapeutic medicine for consumption
|
|
DE69535461T2
(en)
|
1994-10-21 |
2008-09-25 |
NPS Pharmaceuticals, Inc., Salt Lake City |
CALCIUM RECEPTOR ACTIVE COMPOUNDS
|
|
US5756123A
(en)
|
1994-12-01 |
1998-05-26 |
Japan Elanco Co., Ltd. |
Capsule shell
|
|
US6376479B1
(en)
|
1995-04-03 |
2002-04-23 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
|
US20040043971A1
(en)
|
1995-04-03 |
2004-03-04 |
Bone Care International, Inc. |
Method of treating and preventing hyperparathyroidism with active vitamin D analogs
|
|
US6242434B1
(en)
|
1997-08-08 |
2001-06-05 |
Bone Care International, Inc. |
24-hydroxyvitamin D, analogs and uses thereof
|
|
US20020183288A1
(en)
|
1995-04-03 |
2002-12-05 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
|
NZ501318A
(en)
|
1995-09-21 |
2001-07-27 |
Wisconsin Alumni Res Found |
Medicaments containing 25 hydroxy vitamin D (calcitriol) derivatives
|
|
DE19549243A1
(en)
|
1995-12-21 |
1997-06-26 |
Schering Ag |
Pharmaceutical preparations containing clathrates of cyclodextrins and unnatural vitamin D analogues
|
|
US5939408A
(en)
|
1996-05-23 |
1999-08-17 |
Hoffman-La Roche Inc. |
Vitamin D3 analogs
|
|
NO971934L
(en)
|
1996-05-23 |
1997-11-24 |
Hoffmann La Roche |
Fluorinated vitamin D3 analogues
|
|
ID18079A
(en)
|
1996-08-26 |
1998-02-26 |
Takeda Chemical Industries Ltd |
PHARMACEUTICAL COMPOSITION THAT CONTAINS FASTEST OSTEOGENESIS
|
|
US5958451A
(en)
|
1996-09-03 |
1999-09-28 |
Yung Shin Pharm Ind. Co., Ltd. |
Process for producing porous, controlled-release capsules and encapsulated composition
|
|
US5976784A
(en)
|
1996-09-20 |
1999-11-02 |
Wisconsin Alumni Research Foundation |
Calcitriol derivatives and their uses
|
|
US8828432B2
(en)
|
1996-10-28 |
2014-09-09 |
General Mills, Inc. |
Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
|
|
EP0935523B1
(en)
|
1996-10-28 |
2004-09-29 |
Inc. General Mills |
Embedding and encapsulation of controlled release particles
|
|
JPH10158171A
(en)
|
1996-12-02 |
1998-06-16 |
Kita:Kk |
Intraocular administrating agent formulating vitamin d compound therein
|
|
US6503893B2
(en)
|
1996-12-30 |
2003-01-07 |
Bone Care International, Inc. |
Method of treating hyperproliferative diseases using active vitamin D analogues
|
|
US20020128240A1
(en)
|
1996-12-30 |
2002-09-12 |
Bone Care International, Inc. |
Treatment of hyperproliferative diseases using active vitamin D analogues
|
|
US20030129194A1
(en)
|
1997-02-13 |
2003-07-10 |
Bone Care International, Inc. |
Targeted therapeutic delivery of vitamin D compounds
|
|
US6034075A
(en)
|
1997-03-20 |
2000-03-07 |
The Trustees Of Columbia University In The City Of New York |
Method of treating polycystic ovarian syndrome
|
|
US5872113A
(en)
|
1997-05-16 |
1999-02-16 |
Syntex (U.S.A.) Inc. |
Fluorinated vitamin D3 analogs
|
|
ATE322892T1
(en)
|
1997-07-02 |
2006-04-15 |
Euro Celtique Sa |
STABILIZED SUSTAINED-RELEASE TRAMADOL FORMULATIONS
|
|
JPH1175863A
(en)
|
1997-07-10 |
1999-03-23 |
Kyowa Hakko Kogyo Co Ltd |
25-Hydroxyvitamin D3-1α-hydroxylase and DNA encoding the enzyme
|
|
US6096876A
(en)
|
1997-08-06 |
2000-08-01 |
Shriners Hospitals For Children |
1-α-hydroxylase materials and methods
|
|
AU9376998A
(en)
|
1997-09-02 |
1999-03-22 |
Johns Hopkins University School Of Medicine, The |
Vitamin d3 analog loaded polymer formulations for cancer and neurodegenerative disorders
|
|
US5919986A
(en)
|
1997-10-17 |
1999-07-06 |
Hoffmann-La Roche Inc. |
D-homo vitamin D3 derivatives
|
|
JPH11158074A
(en)
|
1997-12-03 |
1999-06-15 |
Hayashi Tomie |
Amino acid-rich active vitamin d potentiation composition
|
|
US20030059471A1
(en)
|
1997-12-15 |
2003-03-27 |
Compton Bruce Jon |
Oral delivery formulation
|
|
CN1301298A
(en)
|
1998-03-25 |
2001-06-27 |
卡坦诺根公司 |
Methods for preventing and treating cancer
|
|
ES2368824T3
(en)
|
1998-03-27 |
2011-11-22 |
Oregon Health & Science University |
VITAMIN D AND ITS ANALOGS IN THE TREATMENT OF TUMORS AND OTHER HYPERPROLIFERATIVE DISORDERS.
|
|
US6197340B1
(en)
|
1998-05-28 |
2001-03-06 |
Medical Research Institute |
Controlled release lipoic acid
|
|
US8133694B2
(en)
|
1998-06-25 |
2012-03-13 |
Immundiagnostik Ag |
Functional vitamin D derivatives and method of determining 25-hydroxy- and 1α, 25-dihydroxy vitamin D
|
|
US6214376B1
(en)
|
1998-08-25 |
2001-04-10 |
Banner Pharmacaps, Inc. |
Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture
|
|
DE69942928D1
(en)
|
1998-08-27 |
2010-12-23 |
Pfizer Health Ab |
THERAPEUTIC FORMULATION FOR THE ADMINISTRATION OF TOLTERODIN WITH CONTROLLED RELEASE
|
|
SE9803871D0
(en)
|
1998-11-11 |
1998-11-11 |
Pharmacia & Upjohn Ab |
Therapeutic method and formulation
|
|
US6139875A
(en)
|
1998-09-29 |
2000-10-31 |
Eastman Chemical Company |
Aqueous enteric coating composition and low gastric permeability enteric coating
|
|
AU6283299A
(en)
|
1998-10-01 |
2000-04-17 |
Elan Pharma International Limited |
Controlled release nanoparticulate compositions
|
|
ATE429813T1
(en)
|
1998-10-09 |
2009-05-15 |
Gen Mills Inc |
ENCAPSULATION OF SENSITIVE LIQUID COMPONENTS INTO A MATRIX TO OBTAIN DISCRETE STORAGE-Stable PARTICLES
|
|
JP3449253B2
(en)
|
1998-10-29 |
2003-09-22 |
シオノギクオリカプス株式会社 |
Manufacturing method of hard capsule
|
|
JP2000206312A
(en)
|
1998-11-12 |
2000-07-28 |
Olympus Optical Co Ltd |
Optical element
|
|
MXPA01006108A
(en)
|
1998-12-17 |
2002-09-18 |
Alza Corp |
Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings.
|
|
US6342249B1
(en)
|
1998-12-23 |
2002-01-29 |
Alza Corporation |
Controlled release liquid active agent formulation dosage forms
|
|
US6432936B1
(en)
|
1999-01-20 |
2002-08-13 |
Wisconsin Alumni Research Foundation |
Crystalline 1α-hydroxyvitamin D2 and method of purification thereof
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
EP1745787B1
(en)
|
1999-04-01 |
2016-11-09 |
Johns Hopkins University |
NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1-alpha 25-DIHYDROXY VITAMIN D3
|
|
US7648826B1
(en)
|
1999-04-02 |
2010-01-19 |
The Regents Of The University Of California |
Detecting CYP24 expression level as a marker for predisposition to cancer
|
|
DE19916419B4
(en)
|
1999-04-08 |
2005-06-16 |
Schering Ag |
Combination preparation of vitamin D metabolites or vitamin D analogues and an estrogen partial agonist for the treatment of osteoporosis
|
|
WO2000072831A1
(en)
|
1999-05-27 |
2000-12-07 |
Drugtech Corporation |
Nutritional formulations
|
|
US6340473B1
(en)
|
1999-07-07 |
2002-01-22 |
R.P. Scherer Technologies, Inc. |
Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
|
|
US6051567A
(en)
|
1999-08-02 |
2000-04-18 |
Abbott Laboratories |
Low oxygen content compositions of 1α, 25-dihydroxycholecalciferol
|
|
US6274169B1
(en)
|
1999-08-02 |
2001-08-14 |
Abbott Laboratories |
Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol
|
|
HK1046851A1
(en)
|
1999-08-31 |
2003-01-30 |
Chugai Seiyaku Kabushiki Kaisha |
Soft capsules
|
|
US20060034937A1
(en)
|
1999-11-23 |
2006-02-16 |
Mahesh Patel |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
GB0007419D0
(en)
|
2000-03-27 |
2000-05-17 |
Smithkline Beecham Gmbh |
Composition
|
|
US6375981B1
(en)
|
2000-06-01 |
2002-04-23 |
A. E. Staley Manufacturing Co. |
Modified starch as a replacement for gelatin in soft gel films and capsules
|
|
EP2070911A2
(en)
|
2000-07-18 |
2009-06-17 |
Bone Care International, Inc. |
Stabilized 1Alpha-Hydroxy vitamin D
|
|
US6491950B1
(en)
|
2000-08-07 |
2002-12-10 |
Kos Pharmaceuticals, Inc. |
Controlled release pharmaceutical composition
|
|
JP4596732B2
(en)
|
2000-08-29 |
2010-12-15 |
日新化成株式会社 |
Hard capsule
|
|
US6887493B2
(en)
|
2000-10-25 |
2005-05-03 |
Adi Shefer |
Multi component controlled release system for oral care, food products, nutraceutical, and beverages
|
|
EP2932964A1
(en)
|
2000-10-30 |
2015-10-21 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
|
US6479649B1
(en)
|
2000-12-13 |
2002-11-12 |
Fmc Corporation |
Production of carrageenan and carrageenan products
|
|
JP2002302447A
(en)
|
2001-04-03 |
2002-10-18 |
Shimizu Pharmaceutical Co Ltd |
Cancer therapeutic agent for topical administration
|
|
CZ20033116A3
(en)
|
2001-05-15 |
2004-09-15 |
Warner-Lambert Company Llc |
Process for preparing dosage form of sodium phenytoin employing compactor
|
|
US7846475B2
(en)
|
2001-07-05 |
2010-12-07 |
Wakunaga Pharmaceutical Co., Ltd. |
Soft capsules
|
|
US6870833B2
(en)
|
2001-07-20 |
2005-03-22 |
Net2Phone, Inc. |
Active voice messaging
|
|
US7166585B2
(en)
|
2001-08-22 |
2007-01-23 |
Cytochroma Inc. |
24-Sulfur-substituted analogs of 1α,25-dihydroxy vitamin D3
|
|
US7033996B2
(en)
|
2001-08-31 |
2006-04-25 |
University Of Medicine & Dentistry Of New Jersey |
Method for the treatment of vitamin D related disease
|
|
DE10149674A1
(en)
|
2001-10-09 |
2003-04-24 |
Apogepha Arzneimittel Gmbh |
Orally administered composition for sustained release of propiverine, useful for treatment of hypertonic bladder disorders, especially by once-daily administration
|
|
PT1436257E
(en)
|
2001-10-12 |
2007-05-31 |
Cytochroma Inc |
Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3
|
|
US6524788B1
(en)
|
2001-11-02 |
2003-02-25 |
Thomas L. Cantor |
Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
|
|
US7056655B2
(en)
|
2001-11-02 |
2006-06-06 |
Scantibodies Laboratory, Inc. |
Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
|
|
ITMI20012366A1
(en)
|
2001-11-09 |
2003-05-09 |
Farmatron Ltd |
THERAPEUTIC SYSTEMS STABILIZED WITH IMMEDIATE RELEASE AND / OR MODIFIED FOR THE ORAL ADMINISTRATION OF ACTIVE AND / OR EXCIPIENT PRINCIPLES AND / OR WINGS
|
|
AU2002366038B2
(en)
|
2001-11-22 |
2007-08-02 |
Morishita Jintan Co., Ltd. |
Non-gelatinous capsule film compositions and capsules using the same
|
|
GB0128415D0
(en)
|
2001-11-27 |
2002-01-16 |
Univ Sheffield |
Medicaments
|
|
KR20050044655A
(en)
|
2001-12-03 |
2005-05-12 |
노바세아, 인크. |
Pharmaceutical compositions comprising active vitamin d compounds
|
|
US6627622B2
(en)
|
2002-02-18 |
2003-09-30 |
Wisconsin Alumni Research Foundation |
(20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
|
|
FR2829142B1
(en)
|
2001-12-27 |
2004-02-13 |
Ulice |
FILMOGENEOUS COMPOSITION OF HETEROXYLANE FOR THE MANUFACTURE OF CAPSULES THUS OBTAINED
|
|
US7632518B2
(en)
|
2002-01-15 |
2009-12-15 |
Dsm Ip Assets B.V. |
25-hydroxy vitamin D3 compositions
|
|
US6949256B2
(en)
|
2002-01-18 |
2005-09-27 |
Banner Pharmacaps, Inc. |
Non-gelatin capsule shell formulation
|
|
NO20021592D0
(en)
|
2002-04-04 |
2002-04-04 |
Fmc Biopolymer As |
Polysaccharide Capsules and Method of Preparation thereof
|
|
US20030195171A1
(en)
|
2002-04-05 |
2003-10-16 |
Daifotis Anastasia G. |
Method for inhibiting bone resorption with an alendronate and vitamin D formulation
|
|
CA2481486C
(en)
|
2002-04-10 |
2012-06-12 |
Fred H. Miller |
Multi-phase, multi-compartment capsular system
|
|
WO2003093459A1
(en)
|
2002-05-02 |
2003-11-13 |
Cytochroma Inc. |
Stable cytochrome p450 24 (cyp24) expressing cell line and methods and uses thereof
|
|
CA2488334C
(en)
|
2002-06-13 |
2010-12-07 |
Johns Hopkins University |
24-sulfoximine vitamin d3 compounds
|
|
PL374922A1
(en)
|
2002-07-05 |
2005-11-14 |
Temrel Limited |
Controlled release composition
|
|
TWI336260B
(en)
|
2002-07-25 |
2011-01-21 |
Glaxo Group Ltd |
Dosage form suitable for retaining drug substance
|
|
DK1539115T3
(en)
|
2002-07-29 |
2008-01-28 |
Alza Corp |
Methods and dosage forms for controlled delivery of paliperidone
|
|
US8268352B2
(en)
|
2002-08-05 |
2012-09-18 |
Torrent Pharmaceuticals Limited |
Modified release composition for highly soluble drugs
|
|
AU2002368245A1
(en)
|
2002-09-26 |
2004-04-19 |
Young-Kweon Choi |
Matrix type patch for transdermal administration of vitamin d analog and the use thereof
|
|
US20050101576A1
(en)
|
2003-11-06 |
2005-05-12 |
Novacea, Inc. |
Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes
|
|
US8999372B2
(en)
|
2002-11-14 |
2015-04-07 |
Cure Pharmaceutical Corporation |
Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
|
|
JP2004175750A
(en)
|
2002-11-28 |
2004-06-24 |
Kose Corp |
Dermopathy inhibitor and dermopathy improving agent, and skin care preparation for external use containing them
|
|
US20050026877A1
(en)
|
2002-12-03 |
2005-02-03 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
JP2006514695A
(en)
|
2002-12-16 |
2006-05-11 |
テバ ファーマシューティカル インダストリーズ リミティド |
Method for enhancing the overall utilization efficiency of alendronate or other bisphosphonates by pre-dose administration of vitamin D derivatives
|
|
DE20321698U1
(en)
|
2002-12-16 |
2008-12-24 |
Teva Pharmaceutical Industries Ltd. |
A medicament for increasing the bioavailability of alendronate or another bisphosphonate by administering a pre-dose of a vitamin D derivative
|
|
WO2004054968A2
(en)
|
2002-12-18 |
2004-07-01 |
Johns Hopkins University |
25-so2-substituted analogs of 1alpha, 25-dihydroxyvitamin d3 (calcitriol)
|
|
CA2515641A1
(en)
|
2003-02-11 |
2004-08-26 |
Alza Corporation |
Methods and dosage forms with modified layer geometry
|
|
US7816341B2
(en)
|
2003-04-14 |
2010-10-19 |
Fmc Corporation |
Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom
|
|
MXPA05011026A
(en)
|
2003-04-14 |
2005-12-12 |
Fmc Corp |
HOMOGENOUS THERMO-REVERSIBLE GEL FILM CONTAINING KAPPA-2 CARRAGENAN AND SOFT CAPSULES MADE FROM THE SAME.
|
|
EP1677802A2
(en)
|
2003-04-30 |
2006-07-12 |
Bioxell S.p.a. |
1,3 aclyated 24-keto-vitamin d3 compounds and methods of use thereof
|
|
JP5049589B2
(en)
|
2003-05-07 |
2012-10-17 |
オステオロジックス エイ／エス |
Controlled release compositions containing strontium salts
|
|
EP1479677A1
(en)
|
2003-05-19 |
2004-11-24 |
Aventis Pharma Deutschland GmbH |
New indole derivatives as factor xa inhibitors
|
|
US7207965B2
(en)
|
2003-06-16 |
2007-04-24 |
Solx, Inc. |
Shunt for the treatment of glaucoma
|
|
ES2379466T3
(en)
|
2003-06-26 |
2012-04-26 |
Psivida Us, Inc. |
Bio-erasable sustained release drug delivery system
|
|
AU2003903382A0
(en)
|
2003-07-03 |
2003-07-17 |
Medvet Science Pty Ltd |
Inhibition of calcitriol mediated cyp24 induction screening for compounds therefor and uses thereof
|
|
EP1643978A1
(en)
|
2003-07-04 |
2006-04-12 |
Nycomed Danmark A/S |
Parathyroid hormone (pth) containing pharmaceutical compositions for oral use
|
|
US20050148557A1
(en)
|
2003-07-29 |
2005-07-07 |
Jin Tian |
Use of Vitamin Ds to treat kidney disease
|
|
US20050124591A1
(en)
|
2003-07-29 |
2005-06-09 |
Jin Tian |
Use of vitamin Ds to treat kidney disease
|
|
HUE044822T2
(en)
|
2003-09-12 |
2019-11-28 |
Amgen Inc |
Rapid dissolution formulation of cinacalcet hcl
|
|
US7053075B2
(en)
|
2003-11-25 |
2006-05-30 |
Deluca Hector F |
Methods for reducing body fat using vitamin D compounds
|
|
US7427670B2
(en)
|
2003-12-19 |
2008-09-23 |
Cytochroma Inc. |
Cytochrome P450 24 (CYP24) monoclonal antibody and methods and uses thereof
|
|
US20060009425A1
(en)
|
2004-05-28 |
2006-01-12 |
Leticia Delgado-Herrera |
Oral formulations of paricalcitol
|
|
JP2008502605A
(en)
|
2004-06-16 |
2008-01-31 |
スマート ドラッグ システムズ インコーポレイティド |
Sustained release vaccine composition
|
|
WO2006007323A2
(en)
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
Dosage forms for low solubility and/or low dissolution rate free acid pharmaceutical agents
|
|
US20060019933A1
(en)
|
2004-07-22 |
2006-01-26 |
David Boardman |
Process for preparing stabilized vitamin D
|
|
KR20070043806A
(en)
|
2004-07-29 |
2007-04-25 |
사노피-아벤티스 |
Pharmaceutical Multi-Layered Tablets for Controlled Release of Active Ingredients Soluble Highly Dependent on pH
|
|
US8231896B2
(en)
|
2004-11-08 |
2012-07-31 |
R.P. Scherer Technologies, Llc |
Non-gelatin soft capsule system
|
|
AU2004325362B2
(en)
|
2004-12-03 |
2012-09-06 |
Council Of Scientific And Industrial Research |
Process of preparation of biodegradable films from semi refined kappa carrageenan
|
|
US8318210B2
(en)
|
2005-02-28 |
2012-11-27 |
Neos Therapeutics, Lp |
Compositions and methods of making sustained release liquid formulations
|
|
US7745226B2
(en)
|
2005-04-06 |
2010-06-29 |
Quest Diagnostics Investments Incorporated |
Methods for detecting vitamin D metabolites
|
|
PL2985026T3
(en)
|
2005-04-15 |
2023-02-20 |
Clarus Therapeutics, Inc. |
Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
|
|
US20060257481A1
(en)
|
2005-04-21 |
2006-11-16 |
Decode Genetics Ehf. |
Sustained release formulation and dosing schedule of leukotriene synthesis inhibitor for human therapy
|
|
US9205047B2
(en)
|
2005-04-25 |
2015-12-08 |
The Governing Council Of The University Of Toronto |
Tunable sustained release of a sparingly soluble hydrophobic therapeutic agent from a hydrogel matrix
|
|
US20080134937A1
(en)
|
2005-05-25 |
2008-06-12 |
Joo Hwan Yang |
Cellulose hard capsule enhancing mechanical film strength
|
|
AR055099A1
(en)
|
2005-07-28 |
2007-08-08 |
Alza Corp |
LIQUID FORMULATIONS FOR THE CONTROLLED ADMINISTRATION OF BENCISOXAZOL DERIVATIVES
|
|
WO2007039193A1
(en)
|
2005-09-29 |
2007-04-12 |
Roche Diagnostics Gmbh |
Antibodies against 25-hydroxyvitamin d
|
|
ITFI20050206A1
(en)
|
2005-09-30 |
2007-04-01 |
Valpharma Sa |
PHARMACEUTICAL COMPOSITION OF CONTROLLED RELEASE OF VENLAFAXINE CHLORIDRATE, AND PROCESS FOR ITS PREPARATION
|
|
JP5303276B2
(en)
|
2005-10-12 |
2013-10-02 |
プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー |
Methods and products for treating 25-hydroxyvitamin D deficiency and deficiency
|
|
EP1951208A2
(en)
|
2005-10-26 |
2008-08-06 |
Banner Pharmacaps Inc. |
Lipophilic vehicle-based dual controlled release matrix system as capsule fill
|
|
WO2007050975A2
(en)
|
2005-10-26 |
2007-05-03 |
Banner Pharmacaps, Inc. |
Hydrophilic vehicle-based dual controlled release matrix system as capsule fill
|
|
MX2008005643A
(en)
|
2005-11-01 |
2008-12-09 |
Cp Kelco Inc |
High viscosity diutan gums and methods of producing.
|
|
WO2007068287A1
(en)
|
2005-12-15 |
2007-06-21 |
Laboratoria Qualiphar |
Sustained release vitamin preparation
|
|
MXPA05014091A
(en)
|
2005-12-20 |
2007-06-20 |
Leopoldo De Jesus Espinosa Abdala |
Pharmaceutical compositions containing synthetic steroid derivatives such as tibolone, minerals such as calcium and the active metabolite of vitamin d (calcitrol) for the prevention and treatment of osteoporosis and menopause.
|
|
CN101448955A
(en)
|
2006-01-31 |
2009-06-03 |
健康研究股份有限公司 |
Method for identifying altered vitamin D metabolism
|
|
US7528122B2
(en)
|
2006-02-02 |
2009-05-05 |
Wisconsin Alumni Research Foundation |
Vitamin D analog—NEL, methods and uses thereof
|
|
CA2882048C
(en)
|
2006-02-03 |
2020-03-24 |
Proventiv Therapeutics, Llc |
Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
|
|
GB0606426D0
(en)
|
2006-03-30 |
2006-05-10 |
Novartis Ag |
Benzimidazole derivatives
|
|
EP2024436A1
(en)
|
2006-06-06 |
2009-02-18 |
Fmc Corporation |
Kappa-2 carrageenan composition and products made therefrom
|
|
US20080109983A1
(en)
|
2006-11-10 |
2008-05-15 |
Kegel, Llc |
Zero Turning Radius Lane Maintenance Machine
|
|
EP2679228B1
(en)
|
2006-06-21 |
2018-03-21 |
Opko Ireland Global Holdings, Ltd. |
Therapy using vitamin D repletion agent and vitamin D hormone replacement agent
|
|
EP1912400A1
(en)
|
2006-10-10 |
2008-04-16 |
Matsushita Electric Industrial Co., Ltd. |
Method and apparatus for mobile IP route optimization
|
|
US20100168410A1
(en)
|
2006-10-27 |
2010-07-01 |
Pfizer Products Inc. |
Hydroxypropyl Methyl Cellulose Hard Capsules and Process of Manufacture
|
|
WO2008097646A1
(en)
|
2007-02-09 |
2008-08-14 |
Schering Corporation |
Methods to treat and/or prevent mucositis
|
|
US8491937B2
(en)
|
2007-02-15 |
2013-07-23 |
Wyeth Llc |
Stability in vitamin and mineral supplements
|
|
US7893357B2
(en)
|
2007-03-20 |
2011-02-22 |
Electrolock, Inc. |
Roebel winding with conductive felt
|
|
EP2136814A4
(en)
|
2007-03-21 |
2012-05-30 |
Univ Duke |
MEDICATION KITS AND FORMULATIONS FOR PREVENTING, TREATING OR REDUCING SECONDARY FRACTURES AFTER ANOTHER FRACTURE
|
|
US8592401B2
(en)
|
2007-04-25 |
2013-11-26 |
Proventiv Therapeutics, Llc |
Methods and compounds for vitamin D therapy
|
|
KR101759244B1
(en)
|
2007-04-25 |
2017-07-18 |
사이토크로마 인코포레이티드 |
Oral controlled release compositions comprising vitamin d compound and waxy carrier
|
|
WO2009047644A2
(en)
|
2007-04-25 |
2009-04-16 |
Cytochroma Inc. |
Method of treating vitamin d insufficiency and deficiency
|
|
EP3225243B1
(en)
|
2007-04-25 |
2025-09-03 |
Opko Renal, LLC |
Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
|
|
US20090004284A1
(en)
|
2007-06-26 |
2009-01-01 |
Watson Pharmaceuticals, Inc. |
Controlled release tamsulosin hydrochloride formulation
|
|
KR100836960B1
(en)
|
2007-09-07 |
2008-06-10 |
주식회사 서울제약 |
New niacin controlled release formulation
|
|
EP2042165A1
(en)
|
2007-09-28 |
2009-04-01 |
Swiss Caps Rechte und Lizenzen AG |
Hot-melt filled soft capsules
|
|
WO2009073946A1
(en)
|
2007-12-12 |
2009-06-18 |
Multi Formulations Ltd. |
Particles in a capsule
|
|
DE102008006203B4
(en)
|
2008-01-26 |
2011-03-17 |
Jost-Werke Gmbh |
Vehicle coupling for establishing a mechanical connection between a first and a second vehicle
|
|
AU2009214048A1
(en)
|
2008-02-13 |
2009-08-20 |
Dsm Ip Assets B.V. |
Treating hypertension with 25-hydroxyvitamin D3
|
|
JP5691072B2
(en)
|
2008-02-13 |
2015-04-01 |
ディーエスエム アイピー アセッツ ビー．ブイ． |
Treatment of hyperglycemia with 25-hydroxyvitamin D3
|
|
BRPI0907951A2
(en)
|
2008-02-13 |
2015-08-04 |
Dsm Ip Assets Bv |
Combined use of 25-hydroxyvitamin d3 and vitamin d3 to improve bone mineral density and to treat osteoporosis
|
|
MX2010008894A
(en)
|
2008-02-13 |
2010-11-05 |
Dsm Ip Assets Bv |
Combination of vitamin d and 25-hydroxyvitamin d 3.
|
|
CN107412237A
(en)
|
2008-02-13 |
2017-12-01 |
帝斯曼知识产权资产管理有限公司 |
25 hydroxycholecalciferols are used for the purposes for influenceing people's muscle physiology
|
|
CN106853250A
(en)
|
2008-04-02 |
2017-06-16 |
赛特克罗公司 |
Method, composition, purposes and kit for vitamin D deficiency and associated disorders
|
|
EP2321273B1
(en)
|
2008-07-24 |
2014-11-19 |
Wisconsin Alumni Research Foundation |
Once-a-week administration of 25-hydroxy vitamin d3 to sustain elevated steady-state pharmacokinetic blood concentration
|
|
CN102164588B
(en)
|
2008-09-24 |
2015-07-08 |
赢创罗姆有限公司 |
PH-dependent controlled release pharmaceutical composition with resistance against the influence of ethanol
|
|
ES2425762T3
(en)
|
2008-10-27 |
2013-10-17 |
Roquette Freres |
Water insoluble polymer: film coatings based on modified starch derivatives for colon-directed release
|
|
GEP20146013B
(en)
|
2009-01-23 |
2014-01-27 |
Aziende Chimiche Riunite Angelini Francesco A C R A F S P A It |
Controlled release pharmaceutical or food formulation and method of preparation thereof
|
|
CH700543A2
(en)
|
2009-03-03 |
2010-09-15 |
Innogel Ag |
Film based on starch.
|
|
KR101760534B1
(en)
|
2009-09-10 |
2017-07-21 |
에프엠씨 코포레이션 |
Seamless alginate capsules
|
|
IT1396937B1
(en)
|
2009-11-26 |
2012-12-20 |
Bruzzese |
FORMULATIONS OF BISPHOSPHONATES AND VITAMIN D SUITABLE FOR INTERMITTENT ADMINISTRATION BY INTRAMUSCULAR AND SUBCUTANEOUS
|
|
FR2953139B1
(en)
|
2009-11-27 |
2012-04-13 |
Servier Lab |
PHARMACEUTICAL COMPOSITION COMPRISING STRONTIUM SALT, VITAMIN D AND CYCLODEXTRIN
|
|
US8101204B2
(en)
|
2010-01-14 |
2012-01-24 |
Karl Wei Cao |
Hard capsule composition and method of use
|
|
US8101203B2
(en)
|
2010-01-14 |
2012-01-24 |
Karl Wei Cao |
Hard capsule composition and method of use
|
|
WO2011095388A1
(en)
|
2010-02-04 |
2011-08-11 |
Synthon Bv |
Tolterodine bead
|
|
SI2552484T1
(en)
|
2010-03-29 |
2020-07-31 |
Opko Ireland Global Holdings, Ltd. |
Methods and compositions for reducing parathyroid levels
|
|
WO2012006475A1
(en)
|
2010-07-07 |
2012-01-12 |
Ardelyx, Inc. |
Compounds and methods for inhibiting phosphate transport
|
|
KR20120005228A
(en)
|
2010-07-08 |
2012-01-16 |
주식회사 네비팜 |
An enteric pharmaceutical composition for the treatment of osteoporosis comprising bisphosphonate and the process thereof
|
|
AU2010358565B2
(en)
|
2010-08-04 |
2016-07-14 |
R.P. Scherer Technologies, Llc |
Film-forming composition for soft capsules
|
|
US20120135103A1
(en)
|
2010-11-30 |
2012-05-31 |
Mead Johnson Nutrition Company |
Staged Infant Feeding Regimen To Promote Healthy Development And Growth
|
|
KR101895764B1
(en)
|
2010-12-06 |
2018-09-07 |
디에스엠 아이피 어셋츠 비.브이. |
Treating conditions associated with increased eotaxin with 25-hydroxyvitamin d3
|
|
AU2011353202B2
(en)
|
2010-12-28 |
2015-07-09 |
Future Diagnostics B.V. |
Release reagent for vitamin D
|
|
EP2680826B1
(en)
|
2011-03-02 |
2017-08-23 |
D3 Pharma Limited |
Vitamin d composition
|
|
JP2014512388A
(en)
|
2011-04-20 |
2014-05-22 |
マイコ・バイオ，インコーポレーテッド |
Compositions and methods for enhancing immune response
|
|
JP5597770B2
(en)
|
2011-04-20 |
2014-10-01 |
サフン カプセル カンパニー， リミテッド |
Non-animal soft capsule coating composition with improved disintegration and coating hardness
|
|
CN102771688A
(en)
|
2011-05-13 |
2012-11-14 |
富曼实（上海）商贸有限公司 |
Edible liquid-filled polysaccharide capsule
|
|
US20130085121A1
(en)
|
2011-09-30 |
2013-04-04 |
Jianguo Wang |
Pharmaceutical compositions comprising phosphate binder, calcium receptor-active compound and/or active vitamin d
|
|
WO2014029953A1
(en)
|
2012-08-21 |
2014-02-27 |
Cipla Limited |
Hot melt extruded (hme) pharmaceutical composition of cinacalcet
|
|
KR101847947B1
(en)
|
2013-03-15 |
2018-05-28 |
옵코 아이피 홀딩스 Ⅱ 인코포레이티드 |
Stabilized modified release vitamin d formulation
|
|
PT106978A
(en)
|
2013-05-31 |
2014-12-02 |
Tecnimede Sociedade Tecnico Medicinal S A |
SOLID ORAL COMPOSITION CONTAINING IBANDRONIC ACID AND VITAMIN D
|
|
EP2815745A1
(en)
|
2013-06-21 |
2014-12-24 |
Swiss Caps Rechte und Lizenzen AG |
Soft shell capsule and process for its manufacture
|
|
CN103520133B
(en)
|
2013-10-26 |
2015-02-04 |
中山市凯博思淀粉材料科技有限公司 |
Preparation method of starch-based soft capsule
|
|
CN103495176B
(en)
|
2013-10-26 |
2015-01-28 |
中山市凯博思淀粉材料科技有限公司 |
Method for preparing starch-based soft capsule by blending extrusion method
|
|
US10220047B2
(en)
|
2014-08-07 |
2019-03-05 |
Opko Ireland Global Holdings, Ltd. |
Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
|
|
KR20170047265A
(en)
|
2014-08-07 |
2017-05-04 |
옵코 아일랜드 글로벌 홀딩스 리미티드 |
Adjunctive therapy with 25-hydroxyvitamin d
|
|
CA3018019A1
(en)
|
2016-03-28 |
2017-10-26 |
Opko Ireland Global Holdings, Limited |
Methods of vitamin d treatment
|